Related Experiment Videos
Effects of hormones on fetal lung development
Matthew J Bizzarro1, Ian Gross
1Division of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine, Children's Hospital WP 493, 333 Cedar Street, P.O. Box 208064, New Haven, CT 06520-8064, USA.
Obstetrics and Gynecology Clinics of North America
|November 20, 2004
Summary
Antenatal glucocorticoids are crucial for fetal lung development and offer significant benefits for premature infants, reducing respiratory distress and mortality. However, optimal use and potential toxicities remain areas of ongoing research and debate.
Area of Science:
- Perinatology
- Neonatology
- Endocrinology
Background:
- Endogenous hormones, particularly glucocorticoids, are vital for fetal lung maturation.
- Antenatal glucocorticoid administration is a key intervention for pregnancies at risk of preterm birth.
Purpose of the Study:
- To review the physiological role of glucocorticoids in fetal lung development.
- To summarize the clinical benefits of antenatal glucocorticoids for neonates.
- To discuss current controversies and potential toxicities associated with this therapy.
Main Methods:
- Review of existing literature on antenatal glucocorticoid therapy.
- Analysis of physiological mechanisms and clinical trial data.
- Discussion of unresolved clinical questions and safety concerns.
Main Results:
- Antenatal glucocorticoids significantly reduce the incidence of respiratory distress syndrome in neonates.
- Therapy is associated with decreased rates of intraventricular hemorrhage and improved neonatal survival.
- Key areas of controversy include drug choice, dosing, and treatment course.
Conclusions:
- Antenatal glucocorticoids provide substantial benefits for preterm infants.
- Further research is needed to optimize treatment protocols and address potential long-term toxicities.